T81.0 T82.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Planned primary implenation of pacemaker or ICD. -Therapy with at least one antiplatelet or an oral anticoagulant - -Age over 18 years -Capacity to consent -Existence of a written informed consent form
Exclusion criteria
Exclusion criteria: -Clear idication for one of the possible prodcedere -Pregnancy -Legally in medical matters supervised patients -Participation in another interventional study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of clinical relevant hematoma are defined by a hematoma-score: - size >20x20cm and decrease of hemoglobin >2 points - palpable mass of hematoma, min. 2 cm - prolongation of hospital stay - pocket infection caused by existing hematoma - reoperation required due to hematoma - running anticoagulation has to be reduced or paused The occurrrence of clinical relevant hematoma will be checked on a) the first postoperative day and b) between the 11.-15. postoperative day. c) after 6 weeks final follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome such as displacement of materials, pocket infections and prolonged wound healing will be mesured by their typically clinical appereance the first day postoperative and between the 11.-15. day after surgery. | — |
Countries
Germany
Contacts
Medizinische Klinik m. S. Kardiologie Rhythmologie-Elektrophysiologie und Devicetherapie; Charité Campus Virchow Klinikum